Compare NNVC & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNVC | MKTW |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 39.7M |
| IPO Year | 2008 | 2020 |
| Metric | NNVC | MKTW |
|---|---|---|
| Price | $1.75 | $20.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 349.7K | 16.3K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 10.20% |
| EPS Growth | 10.00 | ★ 1183.33 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $512,403,000.00 |
| Revenue This Year | N/A | $1.52 |
| Revenue Next Year | N/A | $4.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $13.49 |
| 52 Week High | $2.23 | $21.74 |
| Indicator | NNVC | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 61.20 | 68.01 |
| Support Level | $1.18 | $16.16 |
| Resistance Level | $1.90 | $21.18 |
| Average True Range (ATR) | 0.15 | 0.88 |
| MACD | 0.03 | 0.15 |
| Stochastic Oscillator | 78.18 | 73.07 |
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.